Slideshow

13 Psychiatric Drugs With Novel Mechanisms: A Timeline

Author(s):

John J. Miller, MD

Some speculate the pharmaceutical industry has virtually abandoned new drug development in neuroscience with a few exceptions. However, it should be noted that progress has been made.

Newsletter

Receive trusted psychiatric news, expert analysis, and clinical insights — subscribe today to support your practice and your patients.

Subscribe Now!
Related Videos
McIntyre
John Krystal
peshkova Adobestock
brain connections
schism
electric brain
Related Content
depression
July 25th 2025

Major Depressive Disorder Research Roundup: July 25, 2025

Jessica Walters
Blue Light Blockers: A Behavior Therapy for Mania
October 7th 2021

Blue Light Blockers: A Behavior Therapy for Mania

Chris Aiken, MD Kellie Newsome, PMH-NP
MAOIs
July 24th 2025

Successfully Prescribing MAOIs for Depression

Shalom Feinberg, MD
Blue Light, Depression, and Bipolar Disorder
August 4th 2021

Blue Light, Depression, and Bipolar Disorder

Chris Aiken, MD Kellie Newsome, PMH-NP
depression anxiety
July 17th 2025

First Patient Dosed in Phase 2b Study of GlyphAllo for Patients With Major Depressive Disorder, With or Without Anxious Stress

Leah Kuntz
The 2R Artificiality/Adobe Stock
July 15th 2025

Reduced Parahippocampal Volume Found to Be Related to Major Depressive Disorder in Study Using 7T MRI

Jessica Walters
© 2025 MJH Life Sciences

All rights reserved.